Published in J Magn Reson Imaging on March 01, 2008
Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem. Magn Reson Med (2010) 1.10
Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol Psychiatry (2010) 1.10
Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology (2010) 1.07
Regional neurochemical profiles in the human brain measured by ¹H MRS at 7 T using local B₁ shimming. NMR Biomed (2011) 1.07
Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology (2012) 1.02
Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study. J Neurol (2012) 1.00
Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T. Magn Reson Med (2014) 0.96
Brain metabolite concentrations across cortical regions in healthy adults. Brain Res (2010) 0.91
What have novel imaging techniques revealed about metabolism in the aging brain? Future Neurol (2014) 0.89
Metabolic gray matter changes of adolescents with anorexia nervosa in combined MR proton and phosphorus spectroscopy. Neuroradiology (2012) 0.87
Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis. Brain Pathol (2012) 0.85
Reliable non-invasive measurement of human neurochemistry using proton spectroscopy with an anatomically defined amygdala-specific voxel. Neuroimage (2011) 0.84
Regional and tissue-specific differences in brain glutamate concentration measured by in vivo single voxel MRS. J Neurosci Methods (2014) 0.83
In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging. Neurobiol Aging (2012) 0.82
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Brain (2015) 0.82
Genetic influences on brain developmental trajectories on neuroimaging studies: from infancy to young adulthood. Brain Imaging Behav (2014) 0.80
Evaluation of disease progression in INCL by MR spectroscopy. Ann Clin Transl Neurol (2015) 0.78
Quality of 186 child brain spectra using motion and B0 shim navigated single voxel spectroscopy. J Magn Reson Imaging (2013) 0.78
Magnetic resonance spectroscopic study of radiogenic changes after radiosurgery of cerebral arteriovenous malformations with implications for the differential diagnosis of radionecrosis. Radiat Oncol (2013) 0.76
Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy dogs at 1.5 Tesla. J Vet Sci (2016) 0.75
Detection of Normal Aging Effects on Human Brain Metabolite Concentrations and Microstructure with Whole-Brain MR Spectroscopic Imaging and Quantitative MR Imaging. AJNR Am J Neuroradiol (2015) 0.75
A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool. Acta Vet Scand (2015) 0.75
Age related changes in metabolite concentrations in the normal spinal cord. PLoS One (2014) 0.75
Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med (1993) 15.51
Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed (2000) 8.18
Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med (1993) 5.48
WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B (1994) 3.93
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med (1993) 2.59
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain (2005) 2.17
Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med (1998) 2.10
Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology (1993) 2.09
Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med (2001) 2.03
Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res (1999) 1.86
Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med (1996) 1.72
Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2002) 1.70
Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol (2001) 1.62
Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed (1997) 1.60
Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiol Aging (2005) 1.55
Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol (2001) 1.51
A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex (2001) 1.38
Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med (2000) 1.37
Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla. Magn Reson Med (2007) 1.28
Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed (1993) 1.28
In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging (2002) 1.27
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med (1994) 1.13
Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging (2004) 1.04
MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain. Magn Reson Med (1999) 1.04
Metabolic alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy. Radiology (1995) 0.99
Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum. J Magn Reson Imaging (2002) 0.94
Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging. Magn Reson Med (2002) 0.85
Quantitative proton MR spectroscopic imaging of the mesial temporal lobe. J Magn Reson Imaging (2004) 0.83
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Re-examining the brain regions crucial for orchestrating speech articulation. Brain (2004) 3.23
Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology (2013) 2.79
Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke (2003) 2.61
Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences. Neuroimage (2006) 2.21
A resting state network in the motor control circuit of the basal ganglia. BMC Neurosci (2009) 1.97
MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med (2006) 1.95
Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med (2007) 1.91
Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med (2006) 1.91
Anatomy of spatial attention: insights from perfusion imaging and hemispatial neglect in acute stroke. J Neurosci (2005) 1.75
Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv (2006) 1.65
Restoring cerebral blood flow reveals neural regions critical for naming. J Neurosci (2006) 1.60
Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2002) 1.59
Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging (2013) 1.57
Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int (2013) 1.55
In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med (2007) 1.55
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav (2011) 1.53
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging (2004) 1.40
Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T. Magn Reson Med (2012) 1.33
Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am (2010) 1.31
Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci (2006) 1.30
In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull (2012) 1.28
In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging (2002) 1.27
Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology (2002) 1.21
Neuroimaging correlates of parent ratings of working memory in typically developing children. J Int Neuropsychol Soc (2009) 1.19
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17
Variability in subcortical aphasia is due to variable sites of cortical hypoperfusion. Brain Lang (2004) 1.15
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging (2010) 1.14
High resolution spectroscopic imaging of GABA at 3 Tesla. Magn Reson Med (2010) 1.13
Acceleration of 1H MR metabolic imaging with compressed sensing. Radiology (2013) 1.10
Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med (2013) 1.10
Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging (2006) 1.09
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging (2005) 1.08
Frontal terminations for the inferior fronto-occipital fascicle: anatomical dissection, DTI study and functional considerations on a multi-component bundle. Brain Struct Funct (2011) 1.08
Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology (2003) 1.07
MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol (2011) 1.07
Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage (2013) 1.06
Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol (2003) 1.05
Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging (2009) 1.05
Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol (2010) 1.05
Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging (2004) 1.04
Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke (2002) 1.04
Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria. Radiology (2013) 1.03
Optimized detection of lactate at high fields using inner volume saturation. Magn Reson Med (2006) 1.02
White matter alterations in deficit schizophrenia. Neuropsychopharmacology (2008) 1.02
Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging (2006) 1.01
Correction of symptomatic cerebral malperfusion due to acute type I aortic dissection by transcarotid stenting of the innominate and carotid arteries. J Vasc Surg (2006) 1.00
Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging. AJNR Am J Neuroradiol (2004) 0.99
A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med (2008) 0.99
A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. AJR Am J Roentgenol (2010) 0.98
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol (2010) 0.98
Dual-band water and lipid suppression for MR spectroscopic imaging at 3 Tesla. Magn Reson Med (2010) 0.98
Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med (2002) 0.98
Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme. J Neurooncol (2009) 0.98
Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol (2007) 0.97
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Mov Disord (2012) 0.97
Neural correlates of modality-specific spatial extinction. J Cogn Neurosci (2006) 0.96
Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. J Magn Reson Imaging (2012) 0.94
Quantitative SENSE-MRSI of the human brain. Magn Reson Imaging (2010) 0.94
Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci (2012) 0.94
Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques. J Magn Reson Imaging (2013) 0.93
Measurement of T1 and T2 in the cervical spinal cord at 3 tesla. Magn Reson Med (2008) 0.93
Reproducibility of BOLD signal change induced by breath holding. Neuroimage (2009) 0.93
J-difference editing of gamma-aminobutyric acid (GABA): simulated and experimental multiplet patterns. Magn Reson Med (2012) 0.93
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat (2004) 0.92
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol (2013) 0.92
Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann Neurol (2009) 0.92
Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report. Neurosurgery (2002) 0.91
Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med (2005) 0.91
If J doesn't evolve, it won't J-resolve: J-PRESS with bandwidth-limited refocusing pulses. Magn Reson Med (2011) 0.90
Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients. PLoS One (2012) 0.90
Noninvasive assessment of brain injury in a canine model of hypothermic circulatory arrest using magnetic resonance spectroscopy. Ann Thorac Surg (2006) 0.90
Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol (2005) 0.90
Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia. Radiology (2010) 0.89
Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol (2002) 0.89
Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol (2007) 0.88
Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter. J Magn Reson Imaging (2005) 0.88
Longitudinal and multi-echo transverse relaxation times of normal breast tissue at 3 Tesla. J Magn Reson Imaging (2010) 0.88
Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging. AJNR Am J Neuroradiol (2003) 0.88
Retinotopic mapping in the human visual cortex using vascular space occupancy-dependent functional magnetic resonance imaging. Neuroreport (2005) 0.87
Morphometric and psychometric comparisons between non-substance-abusing patients with posttraumatic stress disorder and normal controls. Psychother Psychosom (2006) 0.87
Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging (2006) 0.87
Adjustable, broadband, selective excitation with uniform phase. J Magn Reson (2002) 0.85
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc Natl Acad Sci U S A (2012) 0.85
Regions of neural dysfunction associated with impaired naming of actions and objects in acute stroke. Cogn Neuropsychol (2002) 0.85
Spin-echo magnetic resonance spectroscopic imaging at 7 T with frequency-modulated refocusing pulses. Magn Reson Med (2012) 0.85
Neuroimaging in leukodystrophies. J Child Neurol (2004) 0.84